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ABSTRACT
Background and Objectives: The safety and efficacy of
female hysteroscopic sterilization using the Essure system
has been well documented. Given the marked differences
in the execution of hysteroscopic and laparoscopic steril-
ization, the objective of this study was to assess the expe-
rience of pain postprocedure between the 2. Secondary
end-points included postoperative pain medication, time
to return to normal activities, postprocedure bleeding, and
patient satisfaction.
Methods: Twenty cases each of laparoscopic sterilization
(LS) and hysteroscopic sterilization (HS) were performed.
Patients were surveyed regarding their experience of pain
immediately postoperatively, 1 week, and 4 weeks post-
procedure.
Results: The average pain score immediately postproce-
dure was significantly lower among HS patients than
among LS patients (t-8.17, P.0001). One-week post-
procedure, none of the patients in the HS group reported
any pain, while the average pain score among the LS
patients was 2.65 (t -9.67, P.0001). Four weeks post-
procedure, women in the HS group continued to report
no pain, 35% of the LS group continued to report some
pain (t-3.04, P.004).
Conclusions: Hysteroscopic sterilization offers a minimally
invasive, less painful, equally efficacious modality for steril-
ization than laparoscopic sterilization and should be avail-
able to all women seeking permanent birth control.
Key Words: Hysteroscopic sterilization, Laparoscopic
sterilization, Essure, Female sterilization, Permanent birth
control.
INTRODUCTION
The safety and efficacy of female hysteroscopic steriliza-
tion using the Essure system (Conceptus, Inc., Mountain
View, CA) has been well documented, and this system is
the only hysteroscopic method of sterilization approved
for use by the FDA.1–4 There are marked differences in the
execution of hysteroscopic and laparoscopic sterilization.
Whereas laparoscopic sterilization is performed with the
administration of general anesthesia in the majority of
cases, hysteroscopic sterilization can be performed with
minimal sedation, as the procedure is less invasive and
involves no incisions. The methods also differ in that
laparoscopic sterilization offers immediate contraception.
The Essure method requires the patient to use a back-up
method of contraception for 3 months postprocedure and
provides confirmation of sterility with a follow-up hys-
terosalpingogram (HSG). Given these distinctions be-
tween the two, it is possible that patient experiences differ
between the methods. Fraser5 reported that pain after
tubal ligation is a significant problem and greatly affects a
patient’s ability to return to normal activities. Reports of
pain after laparoscopic tubal ligation and hysteroscopic
procedures have reported greater pain scores following
laparoscopy. Duffy6 surveyed women who had under-
gone either hysteroscopic sterilization or laparoscopic
sterilization. The data demonstrated an advantage of the
hysteroscopic method over the laparoscopic approach.
The objective of this study was to more thoroughly assess
the experience of pain postprocedure. Patients were sur-
veyed regarding their experience of pain immediately
postoperatively, 1 week, and 4 weeks postprocedure.
Secondary end-points included, postoperative recovery
time, postoperative pain medication, time to return to
normal activities, postprocedure bleeding, and patient sat-
isfaction at 3 months.
METHODS
Study participants were a sample of convenience recruited
at Staten Island University Hospital over a period of 6
months from July 2003 to February 2004. All patients
signed a written consent form. Twenty cases of laparo-
scopic sterilization (LS) were performed using Falope
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SCIENTIFIC PAPERrings, and 20 cases of hysteroscopic sterilization (HS)
were performed using the Essure system. All procedures
were performed in an ambulatory surgical center. All
patients undergoing LS received general anesthesia with
endotracheal intubation. Among the HS cases, 12 were
performed using local anesthesia and IV sedation, and 8
were performed using general anesthesia. Injection Tor-
adol was given 30 to 40 minutes before hysteroscopy to
prevent tubal spasm. To ensure contraception for 3
months postprocedure, all HS patients were given either a
preprocedure injection of Depo Provera or a prescription
for oral contraceptives. Those patients then underwent an
HSG 3 months postprocedure to ensure tubal occlusion.
Postprocedure pain was assessed in the recovery room by
using a scale ranging from 0“No pain” to 10“Worst
pain ever experienced.” Pain scores were compared by
independent t tests, assuming unequal variances, due to
the distributions of the data. Patient satisfaction was as-
sessed 3 months postprocedure by using a scale ranging
from 1% to 100%. Patient report of pain medication use,
return to normal activity, and patient satisfaction was col-
lected via telephone individually by the authors or their
designee after 3 months. The HS patients were surveyed at
their HSG appointment.
RESULTS
Before sterilization, 12.5% of the study participants were
using a barrier method for contraception, 32.5% were
using a hormonal method, 2.5% were using an IUD, and
52.5% reported using no contraception. The patients in
both sterilization groups were similar in parity (LS group
median, 3 children; HS group median, 2) and gravidity
(median, 3 pregnancies among LS patients and 3.5 among
HS patients). Both groups were 40% Caucasian. The HS
patients tended to be older (median, 42.5 years of age)
than the LS patients (median, 38 years). The HS patients
also tended to have lower body mass index (BMI) scores
(BMI mean, 23.52, median, 22.60) than did the LS patients
(BMI mean, 30.11, median, 27.21).
Additional procedures were performed concomitantly in 9
of the 20 (45%) HS cases and in 1 (5%) of the LS cases.
Concomitant procedures are listed in Table 1. Among
cases performed without concomitant procedures, aver-
age HS procedure time was 26 minutes, and average LS
procedure time was 75 minutes. No complications oc-
curred during any of the procedures.
Pain was assessed immediately postoperatively. The av-
erage pain score at that time was significantly lower
among HS patients (mean, 0.60, median, 0) than among LS
patients (mean, 5.05, median, 6; t-8.17, P.0001). Pain
medication postprocedure was required for 3% of the HS
group and 85% of the LS group. All LS patients remained
under observation for 2 hours postprocedure; HS patients
remained an average of 51 minutes.
Pain was assessed again 1 week postprocedure. None of
the patients in the HS group reported any pain, while the
average pain score among the LS patients was 2.65 (me-
dian, 3; t-9.67, P0001). HS patients reported returning
to work an average of 1.35 days after the sterilization
procedure, and LS patients returned to work an average of
14 days postprocedure. Among the LS group, 25% re-
ported minimal spotting, and 75% reported mild bleeding
during the week following the procedure. Within the HS
group, 40% reported minimal spotting, and the remaining
60% reported no bleeding. Four weeks postprocedure, the
women in the HS group continued to report no pain, 35%
of the LS group continued to report some pain (mean pain
score, 0.60, median, 0; t-3.04, P.004). Pain data com-
parisons are summarized in Figure 1.
Table 1.
Procedures Performed Concomitantly With Sterilization
Hysteroscopic Sterilization (n9)
Submucosal resection
Endometrial biopsy (n2)
Vulva biopsy
Fibroid removal
Umbilical hernia repair
Dilatation and curettage (n3)
Laparoscopic Sterilization (n1)
Lysis of omental adhesions
Figure 1. Comparison of mean pain scores at 3 time points after
sterilization.
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within the HS group at 3 months postprocedure. All HS
patients reported 100% satisfaction with the procedure;
the mean satisfaction rating within the LS group was 69%
(median, 60%).
CONCLUSION
The results of this study indicate that patients undergoing
hysteroscopic sterilization experience significantly less
pain than those undergoing laparoscopic sterilization.
While no pain was reported in the hysteroscopic group at
1-week follow-up, some laparoscopic patients continued
to report pain as long as a month following surgery. Our
study has confirmed the findings of Duffy et al6 in their
series published in November 2005. An additional obser-
vation in this study is that in a 2-year follow-up, no
pregnancies have been reported.
There are some weaknesses in this study. Tolerance to pain
was not assessed before the procedures. It is possible that
there was an inherent difference in the pain tolerance be-
tween the members of both groups. The sample size is small
and therefore limits the generalization of the results. All
laparoscopic sterilization procedures were performed using
the Falope ring; therefore, this study cannot address differ-
ences in pain with other methods. In addition, several of the
hysteroscopic patients had other procedures performed con-
comitantly with their sterilizations. However, this is more
likely to increase the potential to experience greater pain
postoperatively, rather than creating a favorable bias.
There are many advantages to hysteroscopic over laparo-
scopic sterilization. Hysteroscopically sterilized patients
do not require general anesthesia, and they receive con-
firmation of their sterilization with a follow-up HSG. Hys-
teroscopic patients in this study reported less pain and
required less postprocedure pain medication than did
laparoscopic patients. Hysteroscopic patients returned to
normal activity sooner and expressed a greater level of
overall satisfaction. However, there are some contraindi-
cations to hysteroscopic sterilization, and not all women
are appropriate candidates. These findings suggest that
hysteroscopic sterilization offers a higher standard of pa-
tient care than laparoscopic sterilization offers, and, where
available, should be offered to women seeking steriliza-
tion.
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